1203O FOLFOX plus nivolumab and ipilimumab versus FOLFOX induction followed by nivolumab and ipilimumab in patients with previously untreated advanced or metastatic adenocarcinoma of the stomach or gastroesophageal junction: Results from the randomized phase II Moonlight trial of the AIO

Autor:	S. Lorenzen, P.C. Thuss-Patience, G. Folprecht, J. Riera Knorrenschild, V. Heinemann, E. Goekkurt, T.N. Dechow, T.J. Ettrich, K.B. Luley, J-C. Moulin, U. Lindig, S. Angermeier, O. Waidmann, D. Pink, C. Bolling, S. Junge, C. Pauligk, T. Gaiser, T.O. Götze, S-E. Al-Batran
Rok vydání:	2022
Předmět:	Oncology Hematology
Zdroj:	Annals of Oncology. 33:S1099
ISSN:	0923-7534
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::82f152cab3569abfd01041cc0609011c https://doi.org/10.1016/j.annonc.2022.07.1321 Zobrazit plný text záznamu